The Globe reports that Eli Lilly, an Indianapolis-based drug company, will establish a $700-million genetic-medicine hub in a 12-story building now under construction on Necco Street - on what was originally supposed to be part of the GE campus. Lilly already has a relatively small outpost in Kendall Square.
↧